Skip to main content
Cardiology Research logoLink to Cardiology Research
. 2018 Aug 10;9(4):244–249. doi: 10.14740/cr728w

Takotsubo Cardiomyopathy-Induced Cardiac Free Wall Rupture: A Case Report and Review of Literature

Mina Iskander a,e, Ashraf Abugroun b, Kerolus Shehata c, Fady Iskander a, Ayman Iskander d
PMCID: PMC6089471  PMID: 30116453

Abstract

Takotsubo cardiomyopathy (TCM) is an acquired form of cardiomyopathy that is commonly seen among post-menopausal women. It is characterized by left ventricular apical ballooning, electrocardiographic changes and mild elevation of cardiac enzymes in the absence of significant coronary artery stenosis. TCM usually has benign course. However, on rare instance, it can result in life-threatening and fatal complications including acute cardiogenic shock, ventricular arrhythmias and ventricular wall rupture. We herein report a case of a 77-year-old female who developed TCM complicated with massive pericardial effusion and cardiac arrest. The patient died and autopsy revealed normal coronaries with a slit-like rupture on the antero-apical surface of the heart extending into the papillary muscle. The clinical course, labs and angiographic findings preceding the cardiac rupture will be outlined. A thorough literature review including review of 14 previously reported case reports of TCM complicated with cardiac rupture will be included.

Keywords: Takotsubo, Cardiomyopathy, Ventricular wall rupture

Introduction

Takotsubo Cardiomyopathy (TCM) is an acquired reversible cardiomyopathy that occurs mostly in postmenopausal females. The condition is relatively rare, account for 1-2% of all suspected acute coronary syndromes [1]. Majority of patients are either Asians or Caucasians. In previously reported cases, 57.2% of patients were Asian, 40% were Caucasian and 2.4% were other races [2]. The pathogenesis of the condition is still unclear, but catecholamine-induced cardiotoxicity has been described as a main potential contributor. TCM simulates acute coronary syndrome (ACS) in its presentation, as it is characterized by acute chest pain with EKG ischemic changes and slight elevation on cardiac enzymes. However, unlike ACS, the condition is characterized by presence of normal coronary arteries on catheterization. TCM has favorable prognosis. Heart failure with or without pulmonary edema is the most commonly seen complications. Rarely, serious complications could arise including development of ventricular arrhythmia, thromboembolic phenomena and ventricular free wall rupture.

Case Report

A 77-year-old female with a history of hypertension was brought to the emergency department (ED) 2 h after she was found unconscious at her apartment. Upon arrival to the ED, she regained her consciousness, but sustained a pressure-like chest pain with mild shortness of breath. She was hemodynamically stable with a blood pressure of 100/72 mm Hg and regular pulse rate of 72 beats/min. Physical examination was within normal limits. Her initial EKG showed a 2 mm ST-segment elevation in leads I, aVL and V2 - V6. Troponin T level was 3.6 ng/mL (reference range is < 0.01 ng/mL). Emergent transthoracic echocardiogram (TTE) showed severe dyskinesia of the anterolateral walls of the left ventricle (LV) with no left ventricular outflow tract (LVOT) obstruction or systolic anterior motion (SAM) of the mitral valve. She was given aspirin, IV heparin, nitroglycerine, thrombolytic therapy, and then was referred to our hospital for escalation of care. Subsequently, a coronary angiography was done and revealed normal coronary arteries with no obstructions, but with a slow flow down the left anterior descending artery (LAD). Left ventriculography (Fig. 1) showed apical ballooning with mild to moderate mitral regurgitation consistent with TCM, she had an ejection fraction of 25% and left ventricular end diastolic pressure (LVEDP) of 35 mm Hg. Shortly after the procedure, the patient suddenly developed a severe sharp chest pain with a rapid drop in her blood pressure. Bedside echocardiogram showed a massive pericardial effusion for which emergent pericardiocentesis was performed. The patient’s condition rapidly deteriorated and developed a cardiac arrest. The patient didn’t respond to the extensive trials of resuscitation and she ultimately expired.

Figure 1.

Figure 1

Left ventriculogram showing the characteristic apical ballooning of TCM with moderate to severe mitral regurgitation.

Gross pathology revealed normal coronary arteries without any atherosclerotic stenosis (Fig. 2). The heart weighs 380 g with a large fresh blood clot on its epicardial surface. There was a 3 × 2 cm area of transmural hemorrhage with a slit-like rupture on the antero-apical surface that extends into the papillary muscles (Fig. 3). Free wall thickness of the right ventricle (RV) was 0.5 cm. and that of LV was 2 cm. Microscopically, there were extensive fresh hemorrhagic foci and neutrophilic infiltration between the cardiac myocytes associated with hyper eosinophilic contraction band necrosis (CBN) (Fig. 4).

Figure 2.

Figure 2

Normal sections of the left anterior descending coronary artery without atherosclerotic stenosis or plaque rupture.

Figure 3.

Figure 3

Mid-ventricular and apical cut sections of the heart showing an area of transmural hemorrhage with an apical slit-like rupture (black arrow).

Figure 4.

Figure 4

Histopathology slides at the rupture site showing areas of hemorrhagic foci with polymorphnuclear cells infiltrates between the cardiac myocytes and hypereosinophilic contraction band necrosis (black arrow).

Discussion

Takotsubo cardiomyopathy (TCM) was first described in a series of Japanese patients by Dote and Sato in 1991 [3]. TCM accounts for 1-2% of cases that present with ACS [1], but it may be underdiagnosed due to a lack of clinical suspicion. The condition is much more common in women, particularly after menopause. Both males and females have similar clinical presentation, trigger factors and prognosis [4].

TCM typically present with chest pain and shortness of press resembling acute MI. It can also present with arrhythmias, pre-syncope or syncope, pulmonary edema or even sudden death. TCM carries a good prognosis and up to 96 % of patients end with complete recovery from their symptoms [5]. Common triggers for the condition include exposure to emotional or physical stressor and in some cases no trigger or precipitant stressor can be identified. EKG changes in TCM include ST segment elevation along precordial leads, T-wave inversion and development of Q-waves. Characteristic angiographic findings of TCM include (LV) apical ballooning lack of significant coronary stenosis [1, 6]. Other variant forms of TCM include isolated basal, mid-ventricular, or apical segment involvement [7]. The revised Mayo Criteria are currently the most commonly used to establish a diagnosis of TCM were a combination of clinical presentation, EKG, TTE and angiographic findings are collectively incorporated in making the diagnosis [8].

Although the exact pathophysiologic mechanisms of TCM is still not well-established, the role of catecholamine seems to be central through the brain-heart axis [9]. Further supporting the role of sympathetic stimulation, Abraham et al described a series of nine patients who developed features of acute stress cardiomyopathy following administration of exogenous sympathomimetic agents [10]. In addition, on a large multi-center study based on the International Takotsubo Registry, patients with TCM had higher prevalence of neurologic and psychiatric problems compared with patients diagnosed with ACS [11]. Although many reports have suggested that the prognosis of TCM is generally favorable with restoration of wall motion in few weeks with conservative therapy, there have been reports of potentially fatal outcomes.

According to TCM registry study, the over-all TCM related mortality was 4.1% and cardiogenic shock developed in 9.9% of patients [11]. Other potential complications of TCM include LV thrombosis [12], development of ventricular septal defect (VSD) [13, 14], mitral regurgitation [15], life-threatening arrhythmias [16] and ventricular free wall rupture (FWR) [17]. Of all the aforementioned complications of TCM, cardiac FWR is the most catastrophic. FWR is extremely rare complication with incidence rate of 0.5% [17]. A review of previously reported cases of TCM complicated with FWR is summarized in Table 1 [18-32].

Table 1. The Demographic, Clinical, Electrocardiographic and Pathologic Features of the Reviewed Cases Along With the Reported Time Interval From Admission to the Occurrence of Cardiac Free Wall Rupture.

Study Age (Y) Gender EKG findings Pathology findings Interval to rupture
Akashi et al [22] 70 F STE in leads I, II, III, aVL, aVF, V2 - V6. Pathologic Q waves were present in leads V1 - V5 Not done 75 h
Ishida et al [27] 67 F STE in leads I, aVL, and V2 - V5 without reciprocal ST depression Not done 7 days
Ohara et al [20] 79 F STE in leads I, aVL and V1 - V5, depression in leads III and aVF, and abnormal Q wave in leads V1 - V4 Rupture in the anterior portion of the LV. Microscopically, inflammatory infiltrates and myocyte necrosis was evident at the site of the rupture with normal surrounding myocardial tissue 7 days
Mafrici et al [28] 87 F STE in the inferior and V2 - V6 leads Not done 1 day
Yamada et al [29] 71 F STE in leads V4 - V6 and abnormal Q waves in leads V4 - V5 Not done 16 h
Sacha et al [24] 81 F STE in leads I, II, III, aVL, aVF, V2 - V6 10 mm apical LV free wall rupture. Microscopically, transmural necrosis with hemorrhage and mild focal PMNL infiltration at the rupture site. Around the rupture, there were multiple fused foci of coagulation necrosis in various phase of myodestruction with contraction band necrosis 44 h
Shinozaki et al [19] 90 F STE in leads I, aVL and V1 - V4 Not done 8 days
Stollberger et al [30] 71 F STE and Q waves in leads II, III, aVF, V5 - V6 5 mm LV rupture in the apico-posterior region 4 h
Tsunoda et al [31] 74 F STE in leads I, aVL, and V3 - V6; ST-depression in leads II, III, aVF; and R-wave diminishment in leads V3 and V4 11mm rupture at the anterior LV wall 30 mm above the apex and a small mural thrombus inside the necrotic wall. Microscopically, there were inflammatory cell infiltrations, interstitial fibrosis, hemorrhage, and coagulation necrosis without evidence of contraction band necrosis 10 days
Kurisu et al [18] 81 F STE in leads I, II, III, aVF and V2 - V6 Not done 64 h
Mendiguchia et al [32] 69 F STE in the anterolateral leads Not done 2 days
Jagszewski et al [23] 82 F STE in leads V1 - V5 Wide penetrating apical rupture. Microscopically, there were hypertrophied and disarrayed cardiomyocytes, surrounded by predominantly mononuclear inflammatory infiltrate and loose connective tissue as well the foci of hemorrhage 5 days
Kumar et al [21] 62 F STE in leads I, II, V5 - V6 Slit-like transmural rupture at the midportion of the posterior ventricular wall with overlying epicardial hemorrhage. Microscopically, there were necrotic fibers with increased eosinophilic staining, contraction band necrosis, along with PMNL infiltration and bundles of wavy myocardial fibers 8 h
Hassan et al [26] 73 M STE and Q waves in the inferior leads and ST depression over the anterolateral leads 1.2 cm perforation at the infero-basal region Not reported
Indorato et al [25] 70 F Not reported 0.4 cm apical rupture with hemorrhagic infarction extending from the anterior to posterior wall of LV. Microscopically, there were neutrophilic infiltration with small areas of spotty necrosis, hemorrhagic changes and a form of catecholaminergic myocarditis 4 h

Risk factors for FWR are similar in both TCM and acute MI and include female gender, advanced age and presence of hypertension [18]. ST elevation in TCM is usually transient and generally recovers within several days after the onset of symptoms [6]. Persistent STE is a warning sign for continued myocardial injury and heralds an impending ventricular FWR [19, 20]. Other predictors for FWR include higher levels of troponin and CPK, elevated LV intramural pressure and wall stress evident with elevated left ventricular outflow tract (LVOT) gradient [21, 22].

FWR is commonly reported among patients with apical form of TCM which may suggest a much more benign course of the mid-ventricular and basal forms of the TCM. Histologically, recognized patterns of myocardial cell death include coagulation necrosis which is also seen in other solid organ infarction, colliquative necrosis that occurs in the low output states and the coagulative myocytolysis with contraction band necrosis (CBN) which is commonly seen on catecholamine myotoxicity [33]. Among patients with TCM complicated with FWR, recognized histopathological patterns of myocardial tissue biopsy include presence of intensely eosinophilic CBN as well as lymphocytic infiltration and localized areas of fibrosis [21, 24, 25]. These findings demonstrate a major role of catecholamines in the pathogenesis of TCM-induced cardiac FWR.

Currently, there is no standard management protocol for patients with TCM. Although β-blockers have been broadly suggested for preventing the progression and recurrence of TCM [34], results from The International Takotsubo Registry suggested that there was no evidence of any survival benefit with the use of β-blockers . The same study demonstrated that the use of angiotensin-converting-enzyme inhibitors (ACE-I) or angiotensin-receptor blockers (ARBs) was associated with improved survival at 1 year. Further studies are needed to clarify the role of β-blockers, ACE-I or ARBs in the prevention of TCM-induced cardiac FWR.

Conclusions

TCM is not a benign disorder. It is associated with a substantial risk for adverse events e.g. arrhythmias, cardiogenic shock, pulmonary edema, systemic thromboembolism, cardiac rupture or even sudden death. Cardiac FWR is an extremely rare but potentially catastrophic complication of TCM. Initial EKG findings of persistently elevated ST-segment in patients with TCM may be useful to predict a more serious course of disease progression and provide a valuable parameter for risk stratification. The pathologic findings at the site of cardiac rupture suggest an important role of catecholamine-induced cardiotoxicity. Further studies are needed to provide an evidence-based guidance on appropriate medical therapy and to investigate the roles of β-blockers and ACE-I in the prevention of TCM-induced cardiac rupture.

Acknowledgments

We thank Dr. James Flynn for his help in the interpretation of the histopathology slides.

Abbreviations

TCM

takotsubo cardiomyopathy

FWR

free wall rupture

RBBB

right bundle branch block

ACS

acute coronary syndrome

LV

left ventricle

RV

right ventricle

STE

ST-segment elevation

CBN

contraction band necrosis

CPK

creatinine phosphokinase

ACE-I

angiotensin converting enzyme inhibitors

ARBs

angiotensin receptor blockers

M

male

F

female

LVEDP

left ventricular end diastolic pressure

LVOT

left ventricular outflow tract

SAM

systolic anterior motion

VSD

ventricular septal defect

EKG

electrocardiogram

MI

myocardial infarction

References

  • 1.Akashi YJ, Goldstein DS, Barbaro G, Ueyama T. Takotsubo cardiomyopathy: a new form of acute, reversible heart failure. Circulation. 2008;118(25):2754–2762. doi: 10.1161/CIRCULATIONAHA.108.767012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Donohue D, Movahed MR. Clinical characteristics, demographics and prognosis of transient left ventricular apical ballooning syndrome. Heart Fail Rev. 2005;10(4):311–316. doi: 10.1007/s10741-005-8555-8. [DOI] [PubMed] [Google Scholar]
  • 3.Dote K, Sato H, Tateishi H, Uchida T, Ishihara M. [Myocardial stunning due to simultaneous multivessel coronary spasms: a review of 5 cases] J Cardiol. 1991;21(2):203–214. [PubMed] [Google Scholar]
  • 4.Wittstein IS, Thiemann DR, Lima JA, Baughman KL, Schulman SP, Gerstenblith G, Wu KC. et al. Neurohumoral features of myocardial stunning due to sudden emotional stress. N Engl J Med. 2005;352(6):539–548. doi: 10.1056/NEJMoa043046. [DOI] [PubMed] [Google Scholar]
  • 5.Elesber AA, Prasad A, Lennon RJ, Wright RS, Lerman A, Rihal CS. Four-year recurrence rate and prognosis of the apical ballooning syndrome. J Am Coll Cardiol. 2007;50(5):448–452. doi: 10.1016/j.jacc.2007.03.050. [DOI] [PubMed] [Google Scholar]
  • 6.Abe Y, Kondo M, Matsuoka R, Araki M, Dohyama K, Tanio H. Assessment of clinical features in transient left ventricular apical ballooning. J Am Coll Cardiol. 2003;41(5):737–742. doi: 10.1016/S0735-1097(02)02925-X. [DOI] [PubMed] [Google Scholar]
  • 7.Hurst RT, Prasad A, Askew JW 3rd, Sengupta PP, Tajik AJ. Takotsubo cardiomyopathy: a unique cardiomyopathy with variable ventricular morphology. JACC Cardiovasc Imaging. 2010;3(6):641–649. doi: 10.1016/j.jcmg.2010.01.009. [DOI] [PubMed] [Google Scholar]
  • 8.Scantlebury DC, Prasad A. Diagnosis of Takotsubo cardiomyopathy. Circ J. 2014;78(9):2129–2139. doi: 10.1253/circj.CJ-14-0859. [DOI] [PubMed] [Google Scholar]
  • 9.Samuels MA. The brain-heart connection. Circulation. 2007;116(1):77–84. doi: 10.1161/CIRCULATIONAHA.106.678995. [DOI] [PubMed] [Google Scholar]
  • 10.Abraham J, Mudd JO, Kapur NK, Klein K, Champion HC, Wittstein IS. Stress cardiomyopathy after intravenous administration of catecholamines and beta-receptor agonists. J Am Coll Cardiol. 2009;53(15):1320–1325. doi: 10.1016/j.jacc.2009.02.020. [DOI] [PubMed] [Google Scholar]
  • 11.Templin C, Ghadri JR, Diekmann J, Napp LC, Bataiosu DR, Jaguszewski M, Cammann VL. et al. Clinical Features and Outcomes of Takotsubo (Stress) Cardiomyopathy. N Engl J Med. 2015;373(10):929–938. doi: 10.1056/NEJMoa1406761. [DOI] [PubMed] [Google Scholar]
  • 12.de Gregorio C, Grimaldi P, Lentini C. Left ventricular thrombus formation and cardioembolic complications in patients with Takotsubo-like syndrome: a systematic review. Int J Cardiol. 2008;131(1):18–24. doi: 10.1016/j.ijcard.2008.05.060. [DOI] [PubMed] [Google Scholar]
  • 13.Izumi K, Tada S, Yamada T. A case of Takotsubo cardiomyopathy complicated by ventricular septal perforation. Circ J. 2008;72(9):1540–1543. doi: 10.1253/circj.CJ-07-0907. [DOI] [PubMed] [Google Scholar]
  • 14.Sakai K, Ochiai H, Katayama N, Nakamura K, Arataki K, Kido T, Iwamoto H. et al. Ventricular septal perforation in a patient with takotsubo cardiomyopathy. Circ J. 2005;69(3):365–367. doi: 10.1253/circj.69.365. [DOI] [PubMed] [Google Scholar]
  • 15.Haghi D, Rohm S, Suselbeck T, Borggrefe M, Papavassiliu T. Incidence and clinical significance of mitral regurgitation in Takotsubo cardiomyopathy. Clin Res Cardiol. 2010;99(2):93–98. doi: 10.1007/s00392-009-0078-1. [DOI] [PubMed] [Google Scholar]
  • 16.Stiermaier T, Eitel C, Denef S, Desch S, Schuler G, Thiele H, Eitel I. Prevalence and Clinical Significance of Life-Threatening Arrhythmias in Takotsubo Cardiomyopathy. J Am Coll Cardiol. 2015;65(19):2148–2150. doi: 10.1016/j.jacc.2015.02.062. [DOI] [PubMed] [Google Scholar]
  • 17.Bybee KA, Kara T, Prasad A, Lerman A, Barsness GW, Wright RS, Rihal CS. Systematic review: transient left ventricular apical ballooning: a syndrome that mimics ST-segment elevation myocardial infarction. Ann Intern Med. 2004;141(11):858–865. doi: 10.7326/0003-4819-141-11-200412070-00010. [DOI] [PubMed] [Google Scholar]
  • 18.Kurisu S, Inoue I. Cardiac rupture in tako-tsubo cardiomyopathy with persistent ST-segment elevation. Int J Cardiol. 2012;158(1):e5–6. doi: 10.1016/j.ijcard.2011.10.059. [DOI] [PubMed] [Google Scholar]
  • 19.Shinozaki K, Tamura A, Abe Y, Yano S, Kadota J. Left ventricular free wall rupture in takotsubo cardiomyopathy. Int J Cardiol. 2007;115(1):e3–4. doi: 10.1016/j.ijcard.2006.05.062. [DOI] [PubMed] [Google Scholar]
  • 20.Ohara Y, Hiasa Y, Hosokawa S, Tomokane T, Yamaguchi K, Ogura R, Miyajima H. et al. Left ventricular free wall rupture in transient left ventricular apical ballooning. Circ J. 2005;69(5):621–623. doi: 10.1253/circj.69.621. [DOI] [PubMed] [Google Scholar]
  • 21.Kumar S, Kaushik S, Nautiyal A, Choudhary SK, Kayastha BL, Mostow N, Lazar JM. Cardiac rupture in takotsubo cardiomyopathy: a systematic review. Clin Cardiol. 2011;34(11):672–676. doi: 10.1002/clc.20957. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Akashi YJ, Tejima T, Sakurada H, Matsuda H, Suzuki K, Kawasaki K, Tsuchiya K. et al. Left ventricular rupture associated with Takotsubo cardiomyopathy. Mayo Clin Proc. 2004;79(6):821–824. doi: 10.1016/S0025-6196(11)62638-4. [DOI] [PubMed] [Google Scholar]
  • 23.Jaguszewski M, Fijalkowski M, Nowak R, Czapiewski P, Ghadri JR, Templin C, Rynkiewicz A. Ventricular rupture in Takotsubo cardiomyopathy. Eur Heart J. 2012;33(8):1027. doi: 10.1093/eurheartj/ehs054. [DOI] [PubMed] [Google Scholar]
  • 24.Sacha J, Maselko J, Wester A, Szudrowicz Z, Pluta W. Left ventricular apical rupture caused by takotsubo cardiomyopathy - comprehensive pathological heart investigation. Circ J. 2007;71(6):982–985. doi: 10.1253/circj.71.982. [DOI] [PubMed] [Google Scholar]
  • 25.Indorato F, Akashi YJ, Rossitto C, Raffino C, Bartoloni G. Takotsubo cardiomyopathy associated with rupture of the left ventricular apex: assessment of histopathological features of a fatal case and literature review. Forensic Sci Med Pathol. 2015;11(4):577–583. doi: 10.1007/s12024-015-9711-7. [DOI] [PubMed] [Google Scholar]
  • 26.S YH. Cardiac rupture in a patient with Takotsubo syndrome triggered by acute myocardial infarction: two messages. Int J Cardiol. 2014;177(1):162–165. doi: 10.1016/j.ijcard.2014.09.108. [DOI] [PubMed] [Google Scholar]
  • 27.Ishida T, Yasu T, Arao K, Kawakami M, Saito M. Images in cardiovascular medicine. Bedside diagnosis of cardiac rupture by contrast echocardiography. Circulation. 2005;112(24):e354–355. doi: 10.1161/CIRCULATIONAHA.105.538348. [DOI] [PubMed] [Google Scholar]
  • 28.Mafrici A, Proietti R, Fusco R, De Biase A, Klugmann S. Left ventricular free wall rupture in a Caucasian female with Takotsubo syndrome: a case report and a brief literature review. J Cardiovasc Med (Hagerstown) 2006;7(12):880–883. doi: 10.2459/JCM.0b013e328010410c. [DOI] [PubMed] [Google Scholar]
  • 29.Ryotaro Yamada NW, Teruyoshi Kume, Takahiro Kawamoto, Noriko Okahashi, Nozomi Wada, Yuji Koyama, Eiji Toyota. et al. Left ventricular rupture associated with takotsubo-like left ventricular dysfunction (Apical Ballooning) J Echocardiogr. 2006;4(2):59–62. [Google Scholar]
  • 30.Stollberger C, Huber JO, Enzelsberger B, Finsterer J. Fatal outcome of epileptic seizure-induced takotsubo syndrome with left ventricular rupture. Eur J Neurol. 2009;16(6):e116–117. doi: 10.1111/j.1468-1331.2009.02619.x. [DOI] [PubMed] [Google Scholar]
  • 31.Tsunoda S, Tando S, Doi T, Kitamura Y, Ogawa M, Tanabe S. et al. Left ventricular free wall rupture associated with a combination of acute myocardial infarction and stress-provoked cardiomyopathy: An autopsy case. J Cardiol Cases. 2010;2(3):e119–e122. doi: 10.1016/j.jccase.2010.05.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Salazar-Mendiguchia J, Ariza A, Sanchez JC, Lorente V, Cequier AR. An unusual complication of a Takotsubo cardiomyopathy: a not so benign disease? Int J Cardiol. 2011;150(3):348–349. doi: 10.1016/j.ijcard.2011.05.035. [DOI] [PubMed] [Google Scholar]
  • 33.Baroldi G. Different morphological types of myocardial cell death in man. Recent Adv Stud Cardiac Struct Metab. 1975;6:383–397. [PubMed] [Google Scholar]
  • 34.Nef HM, Mollmann H, Elsasser A. Tako-tsubo cardiomyopathy (apical ballooning) Heart. 2007;93(10):1309–1315. doi: 10.1136/hrt.2006.101675. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Cardiology Research are provided here courtesy of Elmer Press

RESOURCES